«Neuroscientists are using these new gene - editing and molecular tools to develop potential therapeutic targets across
multiple disease fronts.»
Not exact matches
But for a challenging
disease like MS, attacks on
multiple fronts may be exactly what it takes to help Davis and others who are running out of time.